Book Chapters
Pett SL; Emery S, 2010, 'Atazanavir', in Grayson ML; Crowe SM; McCarthy JS; Mills J; Mouton JW; Norrby SR; Paterson DL; Pfaller MA (ed.), Kucers' the use of antibiotics: A clinical review of antibacterial, antifungal, antiparasitic and antiviral drugs, Hodder Arnold, London, pp. 2830 - 2841
Pett SL; Post JJ, 2009, 'Mycobacterium tuberculosis', in Hoy J; Lewin S; Post JJ; Street A (ed.), HIV Management in Australasia: a guide for clinical care, Australasian Society for HIV Medicine Inc., Darlinghurst, NSW, pp. 149 - 153
Pett SL; Cooper DA, 2008, 'Classification and spectrum', in Mildvan D (ed.), International Atlas of AIDS, 4th ed., Springer, Philadelphia, PA, pp. 77 - 90
Pett SL; Emery S; Cooper DA, 2006, 'Initial treatment of HIV-1 infection. Online access: www.antimicrobe.org', in Singh N; Swindells S; Shafer R (ed.), HIV Clinical Manual, ESun Technologies, LLC, online
Aichelburg A; Pett SL; Cooper DA, 2002, 'AIDS as a World Health Problem', in AIDS as a World Health Problem, MacMillan Publishers, www.els.net, pp. 1 - 6
Aichelburg A; Pett SL; Cooper DA, 2002, 'AIDS: Understanding HIV Transmission', in Encyclopedia of World Sciences, MacMillan Publishers, www.els.net, pp. 1 - 6
Journal articles
Kjærgaard VS; Ledergerber B; Bannister W; Penha RCC; Baker JV; Collins S; Lane HC; Matthews GV; Pett SL; Reilly C; Weintrob A; Milojevic M; Lundgren J, 2026, 'Factors Associated with Persistently Increased IL-6 Levels in People with HIV', Journal of Infectious Diseases, pp. jiag451, http://dx.doi.org/10.1093/infdis/jiag451
Shandu L; Namukwaya S; Seunanden TC; Ngwenya N; Archary M; Kityo C; Ford D; Pett SL; Kekitiinwa AR; Bernays S; Seeley J, 2026, 'Understanding Adolescent Anti-Retroviral Therapy Use in the BREATHER-Plus Trial: Qualitative Findings From South Africa and Uganda', Journal of the International AIDS Society, 29, pp. e70207, http://dx.doi.org/10.1002/jia2.70207
Mason J; Kohli M; Taiwo E; Maan I; Gharib Y; Suonpera E; Barlow M; Olcott F; Waters L; Arenas-Pinto A; Gilson R; Pett S, 2026, 'Switching to doravirine-based antiretroviral therapy without genotypic resistance tests in virologically suppressed people with HIV', AIDS, 40, pp. 1146 - 1151, http://dx.doi.org/10.1097/QAD.0000000000004508
Lee MJ; Cherrill LR; Zacharopoulou P; Collins S; Fumagalli M; Falaschetti E; Altaf M; Tipoe T; Godakandaarachi P; Fox J; Uriel A; Clarke A; Loes SKD; Pett S; Boffito M; Whitlock G; Søgaard OS; Ring K; Mangawa I; Gohil J; Elliott T; Nielsen H; Gunst JD; Orkin C; Sutherland R; Hamzah L; Cicconi P; Taylor GP; Ujetz J; Jahan I; Brown H; Robinson N; Fletcher S; Box H; Seaton KE; Tomaras GD; Ackerman ME; Weiner JA; Kaczynska A; Bittar C; Horowitz J; Nussenzweig MC; Caskey M; Frater J; Fidler S, 2026, 'Time to HIV rebound after infusion of long-acting broadly neutralising antibodies 3BNC117-LS and 10-1074-LS and analytical treatment interruption (the RIO trial): a double-blind, randomised, placebo-controlled trial', Lancet HIV, 13, pp. e527 - e537, http://dx.doi.org/10.1016/S2352-3018(26)00059-7
Baker JV; Siegel LK; Losso MH; Vasudeva S; Nordwall JA; Harper K; Grund B; Havens JP; Fletcher CV; Fishchuk R; Kobrynska O; Abutidze A; Metchurtchlishvili R; Ginde AA; Aggarwal NR; Poulakou G; Mourad A; Gibbs KW; Saito S; Chayakulkeeree M; Mootsikapun P; Honda H; Mateu L; Gyrina O; Garcia A; Lee DG; Casey JD; Jain MK; Bengtson CD; Hite RD; Hiranburana N; Matthay MA; Arizmendez N; Nguyen HH; Drelick A; Mena Lora AJ; Parnia S; Trautner BW; Portsmouth SD; Shimizu R; Uehara T; Paredes R; Goodman AL; Vock DM; Gelijns AC; Weintrob AC; Bajema KL; Pett SL; Lundgren J; Schechner AJ; Higgs ES; Lane HC; Matthews GV; Self WH; Reilly C, 2026, 'Ensitrelvir for the Treatment of Hospitalized Adults With COVID-19: An International Phase 3 Randomized Placebo-controlled Trial', Clinical Infectious Diseases, 83, pp. 59 - 69, http://dx.doi.org/10.1093/cid/ciag272
Lee TC; Barina LA; Walls G; Goodman AL; Yahav D; Cheng MP; Bonten M; Bowen AC; Boyles T; Daneman N; Ekkelenkamp MB; Ghanem-Zoubi N; Hensgens MPM; Jager NGL; Kaasch AJ; Kouijzer IJE; Lewis RJ; Lumley T; Lye DC; McDonald EG; McKew G; McLean ARD; McMullan BJ; McQuilten ZK; Morpeth SC; Paterson DL; Roberts JA; Robinson JO; Saito H; Scarborough M; Ten Oever J; Turner RM; Tverring J; van Hal SJ; Webb SA; Whiteway LM; Arias CA; Henderson A; Heriot GS; Snelling TL; Afra K; Ali SS; Amit S; Anagnostou NA; Archuleta S; Aston SJ; Athan E; Baharav N; Bai AD; Barber BE; Baskaran A; Berkeley MMA; Best EJ; Bhilave NR; Bloomfield MG; Bond KA; Bostock J; Botheras CL; Boyd MA; Bradshaw SME; Briggs EJ; Britton PN; Campbell AJ; Carr BZ; Chancellor JA; Chen K; Cheong EY; Chew KL; Chia PY; Chomba R; Chong BSW; Clews CJN; Cohen JM; Commons RJ; Cutfield T; Daley P; Daniel DS; Davies J; De P; Denholm JT; Di Virgilio M; Dishon-Benattar Y; Dotel R; Duan EH; Easom N; Eliakim-Raz N; England MM; Fahmy M; Findlater AR; Flanagan KL; Foo EZJ; Foo H; Forster DP; Fralick M; Frazer JL; Gador-Whyte AP; Garnham K; German GJ; Ghosh N; Gisolf EH, 2026, 'Cefazolin for Methicillin-Susceptible Staphylococcus aureus Bacteremia', New England Journal of Medicine, 394, pp. 2329 - 2339, http://dx.doi.org/10.1056/NEJMoa2506905
Møller Jensen C; Zargari Marandi R; Moestrup KS; Mourad A; Mena Lora AJ; Sherman BT; Vock DM; Nordwall JA; Carson JM; Peiffer-Smadja N; Aggarwal NR; Naiman NE; Brown SM; Barrett TW; Hatlen T; Kjærgaard VS; Chang W; Sydes MR; Lundgren J; Jensen TO; Polizzotto MN; Nordwall J; Babiker AG; Phillips A; Vock DM; Eriobu N; Kwaghe V; Paredes R; Mateu L; Ramachandruni S; Narang R; Jain MK; Lazarte SM; Baker JV; Frosch AEP; Poulakou G; Syrigos KN; Arnoczy GS; McBride NA; Robinson PA; Sarafian F; Bhagani S; Taha HS; Benfield T; Liu STH; Antoniadou A; Jensen JUS; Kalomenidis I; Susilo A; Hariadi P; Jensen TO; Morales-Rull JL; Helleberg M; Meegada S; Johansen IS; Canario D; Fernández-Cruz E; Metallidis S; Shah A; Sakurai A; Koulouris NG; Trotman R; Weintrob AC; Podlekareva D; Hadi U; Lloyd KM; Røge BT; Saito S; Sweerus K; Malin JJ; Lübbert C; Muñoz J; Cummings MJ; Losso MH; Turner D; Shaw-Saliba K; Dewar R; Highbarger H; Lallemand P; Rehman T; Gerry N; Arlinda D; Chang CC; Grund B; Holbrook MR; Holley HP; Hudson F; McNay LA; Murray DD; Pett SL; Shaughnessy M; Smolskis MC; Touloumi G; Wright ME; Doyle MK; Popik S; Hall C; Ramanathan R; Cao H; Mondou E, 2026, 'Comparing risk factors in severe COVID-19 using machine learning and non-machine learning methods: analysis from 2 international randomized controlled trials', JAMIA Open, 9, http://dx.doi.org/10.1093/jamiaopen/ooag079
Kekitiinwa AR; Jennings A; Bwakura-Dangarembizi M; Kityo C; Siika A; Archary M; Green A; Jafta L; Akabwai GP; Mujuru HA; Mugerwa H; Kiilu C; Mngqibisa R; Seeley J; Nazzinda R; Apoto N; Walker S; Burger D; Giaquinto C; Okello RB; Musoro G; Wambui C; Arumugam T; Conway M; Van Looy N; South A; Bamford A; Thomason MJ; Ford D; Pett SL; Pett S; Ford D; Thomason M; Bamford A; White E; Kirk J; Jennings A; Ainscough H; Dodds R; Bush M; Salomone S; Nguyen H; Omar A; Spittle B; Crawley P; Green A; Pettitt G; Shickle J; Townsend S; Sweeney H; Hook M; Peres S; Sum A; Gibb D; South A; Terre-Torras B; Chappell E; Nolan A; Kekitiinwa A; Katongole F; Nabimba R; Kisekka MN; Mujyanama C; Muzorah GA; Ahimbisibwe G; Namuli F; Namaganda R; Kiyimba L; Baita A; Kikabi RN; Balwa H; Tukamuhebwa S; Aino MB; Tikabibamu J; Kirabira A; Lawrence L; Nantume B; Lutalo M; Anena DL; Kadhuba RJ; Ntege PN; Kembabazi T; Kityo C; Musiime V; Nakabuye S; Namasinga M; Masiga PH; Kabasingo R; Nasaazi C; Wandera C; Kobusingye J; Mulima D; Musiime AV; Mbasani F; Lutalo E; Efrance BN, 2026, 'Efficacy and safety of short-cycle, dolutegravir-based antiretroviral therapy in adolescents living with HIV (BREATHER Plus): a multicentre, open-label, randomised, parallel, two-arm, non-inferiority trial', Lancet HIV, 13, pp. e367 - e379, http://dx.doi.org/10.1016/S2352-3018(25)00326-1
Rasmussen KK; Bannister W; Itenov T; Skeans M; Pett SL; Wendt C; Kunisaki KM; Matthews G; Jordan A; Ulrik CS; Lapperre T; Bojesen RD; Bodtger U; Ilett EE; Benfield T; Sivapalan P; Murray DD; Jensen JUS, 2026, 'Severe Hospitalization-Requiring Viral Infection With Influenza or COVID-19: Metabolic Pathway Analysis', Open Forum Infectious Diseases, 13, http://dx.doi.org/10.1093/ofid/ofag316
Turner HC; Ahmed S; Nguyen HA; Hung LM; Van Nuil J; Thuan DT; Dung NT; Thwaites GE; Walker AS; Chau NVV; Cooke GS; Hallett TB; Ansari A; Barnes E; Bich DT; Khoa DB; Day JN; Flower B; McCabe L; Hoglund RM; Kestelyn E; Kingsley C; Le Ngoc C; Phuong LT; Thao LT; Tran NB; Nguyen Chau A; Tuyen NK; Phuong NN; Pett S; Thach PN; Rahman M; Smith D; Tarning J; Van Doorn R; Quang VM; Thu VT; Hang VK; Huong VT, 2026, 'Economic evaluation of alternative hepatitis C treatment options: a post hoc analysis of the VIETNARMS trial', Eclinicalmedicine, 95, http://dx.doi.org/10.1016/j.eclinm.2026.103969
Yacoub S; Demidova A; Chan XHS; Ajam A; Baimukhambetova D; Horn A; Kakotkina E; Kosenko M; Mursalova A; Van Nuil JI; Phuong CL; Xiao L; Adhikari S; Alzate Alvarez JD; Anderson KB; Avirutnan P; Buchholz S; Chandra R; Chang AY; Quang Chanh H; Consuegra Rodríguez MP; Daniel V; Diaz JV; Figueiredo-Mello C; Gelvez-Ramírez RM; Huyen TB; Kestelyn E; Lam PK; Leopold SJ; Li R; Luu T; Lye DCB; McBride A; Meyer-Andrieux I; Moorman NJ; Nguyen NM; Omar SFS; Ong HC; Ooi EE; Pazukhina E; Pett SL; Porto DB; Rajahram GS; Rogers M; Rojas E; Rosen J; Rylance J; Schilling WHK; Siqueira AM; Sjö P; Sucerquia-Hernandez A; Tam DTH; Teixeira MM; Tietz A; Trieu HT; Unsworth A; Villar L; Waickman AT; Watson JA; Wills BA; Chia PY; Brasil P; Jaenisch T; Lum L; Malavige GN; McGloughlin S; Tirupakuzhi Vijayaraghavan BK; Merson L; Munblit D; Ab Wahab S; Adhikari NK; Ahmed MJ; Arguni E; Aryal D; Bakri A; SL Bastos L; Bhusal S; Blanco L; Caoili J; Celis-Salinas JC; Chaiwang S; Chesnokov A; Claure-Del Granado R; Cruz YV; Dahal A; Dewi R; Fareed K; Felipe Reyes L; Hashmi M; Jayadas TT; Joshi M; Karunananda MV; Katzelnick LC; Kevin M; Lee SW; Leo YS; M N; Marshall J; Mazlan MZ; Mustafa A, 2026, 'Core outcome measurement set for clinical trials in dengue: an international Delphi consensus study (DEN-CORE)', Lancet Infectious Diseases, 26, pp. e231 - e244, http://dx.doi.org/10.1016/S1473-3099(25)00500-6
Anena D; Chappell E; Nazzinda R; Kiilu C; Chitsamatanga M; Arumugam T; Green A; Kityo Mutuluuza C; Bwakura-Dangarembizi M; Siika A; Archary M; Jafta L; Namukwaya S; Seeley J; Akabwai G; Mugerwa H; Bevers L; Burger D; Walker S; Bamford A; South A; Apoto N; Bush M; Thomason MJ; Spittle B; Ford D; Kekitiinwa AR; Pett SL, 2026, 'Trial design and enrolment characteristics of LATA (Long-Acting Treatment in Adolescents): A randomised, open-label, non-inferiority, 96-week trial evaluating the virological efficacy, safety, acceptability and quality-of-life of the dual long-acting injectable regimen cabotegravir/ rilpivirine compared to daily oral therapy in virologically suppressed adolescents with HIV-1 infection, aged 12 to <20 years, in Sub-Saharan Africa', Contemporary Clinical Trials, 162, http://dx.doi.org/10.1016/j.cct.2025.108213
Fumagalli MJ; Kaczynska A; Allombert M; Lopes-Ribeiro Á; de Oliveira Silva M; Hernandez BJ; Lavine C; Espinosa SM; Brown H; Box H; Falaschetti E; Cherrill LR; Elliott T; Lee M; Fox J; Pett S; Clarke A; Uriel A; Sogaard O; Sutherland R; Boffito M; Kinloch-Loes S; Orkin C; Collins S; Zacharopoulou P; Robison N; Bittar C; Oliveira T; Gazumyan A; Jankovic M; Seaman MS; Frater J; Caskey M; Fidler S; Nussenzweig MC, 2026, 'Broadly neutralizing antibodies in adult males living with HIV undergoing analytical treatment interruption: secondary and exploratory outcomes of the phase II randomized controlled RIO trial', Nature Medicine, http://dx.doi.org/10.1038/s41591-026-04644-8
Seunanden TC; Seeley J; Namukwaya S; Shandu L; Bernays S; Archary M; Pett SL; Ford D; Mutuluuza CK; Kekitiinwa AR; Ngwenya N, 2026, 'Pathways of onward HIV disclosure in relationships among young people living with vertically acquired HIV receiving antiretroviral therapy: A qualitative analysis from the BREATHER Plus trial, South Africa', Global Public Health, 21, http://dx.doi.org/10.1080/17441692.2026.2700822
Makusha T; Namukwaya S; Guga P; Ngubo Z; Xulu Z; Nassanga A; Ngwenya N; Bernays S; Archary M; Ford D; Mutuluuza CK; Kekitiinwa AR; Pett SL; Seeley J, 2026, 'The role of parents and caregivers in motivating adolescents with HIV to participate in a long-acting injectable ART clinical trial in South Africa and Uganda', AIDS Care Psychological and Socio Medical Aspects of AIDS HIV, http://dx.doi.org/10.1080/09540121.2026.2635483
McBride A; Chanh HQ; Trieu HT; Tran HB; Anderson KB; Aogo RA; Avirutnan P; Tran LHB; Chan XH; Chandra R; Chang A; Chia PY; Daniel V; Demidova A; Rodriguez MPC; Figueiredo-Mello C; Garcia-Gallo E; Garrood W; Tam DTH; Jaenisch T; Kain M; Katzelnick L; Lam PK; Leopold SJ; Lim C; Siqueira AM; Malavige GN; Malik S; Merson L; Meyer-Andrieux I; Moorman N; Neal A; Nguyen NM; Ong H-C; Pett S; Rojas-Garrido E; Schilling W; Shahrin L; Sjo P; Omar SFS; Teixeira M; Vijayaraghavan BKT; Villar L; Vuong NL; Waickman A; Wills B; Kestelyn E; Watson J; Munblit DB; Yacoub S, 2026, 'Dengue therapeutics consortium 2025: a global collaboration in action', BMJ Public Health, 4, pp. e004043, http://dx.doi.org/10.1136/bmjph-2025-004043
Le Ngoc C; Chai H; Airey G; Das T; Jennings D; Xu F; Flower B; Marjaneh M; McCabe L; Le Manh H; Van Vinh CN; Trong TD; Ngoc TP; Thu HVT; Thwaites GE; van Doorn HR; Day J; Kestelyn E; Le Van T; Rahman M; Pett S; Barnes E; Walker AS; Cooke GS; Ansari MA, 2026, 'Unravelling HCV diversity and resistance in Viet Nam: a cross-sectional analysis', The Lancet Regional Health - Western Pacific, 73, pp. 101956, http://dx.doi.org/10.1016/j.lanwpc.2026.101956
Matthews R; Ellul MA; McKeever S; Pollack T; Houlihan C; Thakur KT; Hsiang-Yi Chou S; Frontera JA; Saylor DR; Chomba M; Moro E; Ray STJ; Semple MG; Smith CJ; Turner MR; Bullmore E; Carson A; Buchan I; Breen G; Solomon T; Nicholson TR; Pett S; Thomas RH; Michael BD, 2025, 'Global & Community Health: What Did the COVID-19 Pandemic Teach Us About Neurologic Surveillance Approaches, and How Should We Be Better Prepared?', Neurology, 105, pp. e214431, http://dx.doi.org/10.1212/WNL.0000000000214431
Rothhaar P; Arand T; Seong HGT; Heuss C; Tulessin M; Wang Z; Förster C; Schneider AC; Quistrebert J; Chai H; Reineke M; Benning L; Honegger J; Hofmann M; Thimme R; Timm J; Walker AS; Barnes EJ; Hudson F; Dennis E; Smith D; Nguyen D; Halford R; McPherson S; Forton D; Wiselka M; Stone B; Ch’ng CL; Nelson M; Bhagani S; Ala A; Barclay ST; Collier JD; Ryder SD; Verma S; Gilson R; Jones C; McCabe L; Pett S; Cooke GS; Schnitzler P; Merle U; Shoukry NH; Bruneau J; Rodrigo C; Lloyd A; Bull RA; Ansari MA; Mogler C; McLauchlan J; Forns X; Pérez-del-Pulgar S; Lohmann V, 2025, 'Highly replicating hepatitis C virus variants emerge in immunosuppressed patients causing severe disease', Nature Communications, 16, http://dx.doi.org/10.1038/s41467-025-67174-w
Sábato S; Benet S; Rogers AJ; Murray TA; Skeans M; Mothe B; Paredes R; Mourad A; Kiweewa F; Kamel D; Jain MK; Lutaakome J; Nalubega MG; Sebudde N; Mylonakis E; Braun DL; Hatlen T; Kimuli I; Kitko C; Mugerwa H; Kitonsa J; Kim K; Tien PC; Highbarger J; McCormack AL; Sanchez A; Murray DD; Babiker AG; Davey VJ; Files DC; Gelijns AC; Higgs ES; Kan VL; Matthews GV; Pett SL; Lane HC; Reilly C; Goodman AL; Lundgren JD; Moltó J; Yeo HP; Diong SH; Ong SWX; Chia PY; Young BE; Uche B; Idoko G; Habib Z; Kwaghe V; Eriobu N; Amodeo A; de Lara CT; Grüttner-Durmaz M; West E; Günthard HF; Martí R; Martínez L; Pena AMM; Morales-Rull JL; Borras B; Otero S; Martínez X; del Amo E; Campins M; Ausín C; Gomez J; Padure S; Di Natale M; Fernández-Cruz E; Muñoz J; Roldan M; Legarda A; Balerdi L; Trilla A; Abad E; Martínez A; Badillo J; Expósito M; Theresa N; Mugerwa O; Okoth I; Nabankema E; Kisuule R; Wangi D; Nalaaki M; Lubega G; Kibirige M; Nabaggala P; Nandhego J; Naluyinda H; Tukamwesiga N; Atukunda A; Segawa I; Mbabazi Q; Kirenga B; Nantongo C; Alum PI; Nyiraguhirwa D; Apio F, 2025, 'SARS-Cov-2 vaccination strategies in hospitalized recovered COVID-19 patients: a randomized clinical trial (VATICO Trial)', Scientific Reports, 15, http://dx.doi.org/10.1038/s41598-025-92742-x
Katongole F; Arumugam T; Jennings A; Mutata C; Ssebunya P; Wamboi C; Green A; Bwakura-Dangarembizi M; Kityo C; Siika A; Archary M; Jafta L; Namukwaya S; Seeley J; Mugerwa H; Walker S; Apoto N; Thomason MJ; Ford D; Pett SL; Kekitiinwa AR; Achida CO; Adhiambo D; Agaba GM; Ahimbisibwe G; Ainscough H; Akabwai GP; Anena DL; Ankunda J; Archary M; Arumugam T; Ashaba J; Asiimwe A; Ategeka J; Atwine A; Ayesiga EW; Bagirigomwa E; Baita A; Balwa H; Bamford A; Bengu SA; Benita MA; Bernays S; Bevers L; Bhiri J; Bobat R; Bosire R; Burger D; Bush M; Butler K; Bwakura-Dangarembizi M; Cebekhulu PS; Chanaiwa VM; Chappell E; Chebet M; Chege C; Chepkoech R; Cheruiyot BK; Cherutich S; Chibanda L; Chidemo T; Chidziva E; Chimanzi J; Chimene S; Chitongo S; Chitsamatanga M; Chivaura R; Choge JC; Clark KS; Colbers A; Conway M; Crawley P; Crawley J; David B; Denis O; Dhibi N; Dodds R; Draleku C; Dube PS; Ekiru WL; Ford N; Francis S; Giaquinto C; Gibb D; Gona SK; Gondo S; Gwande SB; Gwenzi T; Hook M; Jacobs T; Jakait BK; Jennings A; Jepkemboi E; Jepkemboi E; Jepngetich E; Kabasingo R, 2025, 'BREATHER Plus clinical trial design: A randomised non-inferiority trial evaluating the efficacy, safety and acceptability of short cycle (five days on, two days off) dolutegravir/tenofovir-based triple antiretroviral therapy (ART) compared to daily ART in virologically suppressed adolescents living with HIV aged 12 to <20 years in sub-Saharan Africa', Contemporary Clinical Trials, 155, http://dx.doi.org/10.1016/j.cct.2025.107963
Seunanden TC; Ngwenya N; Namukwaya S; Shandu L; Archary M; Mutuluuza CK; Pett SL; Kekitiinwa AR; Bernays S; Seeley J, 2025, 'Living in the shadows: the persistence of secrecy in young people living with HIV on antiretroviral therapy, a qualitative study of the BREATHER Plus trial', Ssm Qualitative Research in Health, 7, http://dx.doi.org/10.1016/j.ssmqr.2025.100560
Cooke GS; Hung LM; Flower B; McCabe L; Hang VTK; Thu VT; Thuan DT; Dung NT; Phuong LT; Khoa DB; An NTC; Thach PN; Huong VTT; Bich DT; Tuyen NK; Ansari MA; Le Ngoc C; Quang VM; Phuong NTN; Thao LT; Tran NB; Kestelyn E; Kingsley C; Van Doorn R; Rahman M; Pett SL; Thwaites GE; Barnes E; Day JN; Chau NVV; Walker AS, 2025, 'Treatment options to support the elimination of hepatitis C: an open-label, factorial, randomised controlled non-inferiority trial', Lancet, 405, pp. 1769 - 1780, http://dx.doi.org/10.1016/S0140-6736(25)00097-2
Pett SL, 2025, 'Predictors of hospitalization, death and incomplete/non-recovery from SARS-CoV-2 in an ambulatory global population', International Journal of Infectious Diseases, 151, http://dx.doi.org/10.1016/j.ijid.2024.107285
Ottaway Z; Campbell L; Fox J; Burns FM; Hamzah L; Schoeman S; Price D; Clarke A; Pett SL; Onyango D; Sabin C; Miller RF; Post FA, 2025, 'Post-acute sequelae of COVID-19 in people of Black ethnicities living with HIV in the United Kingdom', International Journal of STD and AIDS, http://dx.doi.org/10.1177/09564624251334227
Wood GK; Sargent BF; Ahmad ZUA; Tharmaratnam K; Dunai C; Egbe FN; Martin NH; Facer B; Pendered SL; Rogers HC; Hübel C; van Wamelen DJ; Bethlehem RAI; Giunchiglia V; Hellyer PJ; Trender W; Kalsi G; Needham E; Easton A; Jackson TA; Cunningham C; Upthegrove R; Pollak TA; Hotopf M; Solomon T; Pett SL; Shaw PJ; Wood N; Harrison NA; Miller KL; Jezzard P; Williams G; Duff EP; Williams S; Zelaya F; Smith SM; Keller S; Broome M; Kingston N; Husain M; Vincent A; Bradley J; Chinnery P; Menon DK; Aggleton JP; Nicholson TR; Taylor JP; David AS; Carson A; Bullmore E; Breen G; Hampshire A; Zandi MS; Wong SH; Venneri A; Veenith T; Underwood J; Thomson E; Thomas RH; Tamborska A; Taams L; Smith J; Smith CJ; Singh B; Sieradzki A; Shil RSK; Semple S; Seed AW; Sawcer SJ; Samuel M; Salman RAS; Rota S; Roberts A; Pollak TA; Peacock S; Patel A; Palmos A; Ostermann M; Orazulume O; O’Malley R; Nicholas N; Newcombe V; Nair A; Mulholland C; Morris CM; Monssen D; McIntosh AM; McIlwaine R; McKeever S; McGlinchey E; McDonnell G; Mansoori P; Madarshahian D, 2025, 'Posthospitalization COVID-19 cognitive deficits at 1 year are global and associated with elevated brain injury markers and gray matter volume reduction', Nature Medicine, 31, pp. 245 - 257, http://dx.doi.org/10.1038/s41591-024-03309-8
Bevers L; Chappell E; Mutuluuza CK; Mugerwa H; Dangarembizi MB; Weza S; Anena LD; Archary M; Bush M; Green A; Thomason MJ; Ford D; Kekitiinwa AR; Pett SL; Jacobs T; Burger DM, 2025, 'Pharmacokinetics of long‐acting cabotegravir and rilpivirine in virologically suppressed adolescents living with HIV‐1 in Sub‐Saharan Africa: Data from the LATA trial', British Journal of Clinical Pharmacology, 91, pp. 14 - 15, http://dx.doi.org/10.1002/bcp.70219
Jensen TO; Harper K; Gupta S; Liu ST; Dharan NJ; Baker JV; Pett SL; Shaw-Saliba K; Esmail A; Ho MQ; Almasri E; Dewar RL; Lundgren J; Vock DM, 2024, 'Impact of Baseline SARS-CoV-2 Load in Plasma and Upper Airways on the Incidence of Acute Extrapulmonary Complications of COVID-19: A Multicentric, Prospective, Cohort Study', Clinical Infectious Diseases, 79, pp. 1394 - 1403, http://dx.doi.org/10.1093/cid/ciae469
Ko S; Dominguez-Dominguez L; Ottaway Z; Campbell L; Fox J; Burns F; Hamzah L; Ustianowski A; Clarke A; Kegg S; Schoeman S; Jones R; Pett SL; Hudson J; Post FA, 2024, 'Cardiovascular disease risk in people of African ancestry with HIV in the United Kingdom', HIV Medicine, 25, pp. 1289 - 1297, http://dx.doi.org/10.1111/hiv.13706
Griffiths J; Adshead F; Al-Shahi Salman R; Anderson C; Bedson E; Bliss J; Boshoff A; Chen X; Cranley D; Doran P; Dunne F; Gamble C; Gillies K; Hood K; Kavanagh C; Malone J; Mcgregor N; Mcnamara C; Midha E; Moore K; Murphy L; Newman C; O'reilly S; Perkins AM; Pett S; Sydes MR; Whitty L; You F; Fox L; Williamson PR, 2024, 'What is the carbon footprint of academic clinical trials? A study of hotspots in 10 trials', BMJ Open, 14, pp. e088600, http://dx.doi.org/10.1136/bmjopen-2024-088600
De Kretser D; Mora J; Bloomfield M; Campbell A; Cheng MP; Guy S; Hensgens M; Kalimuddin S; Lee TC; Legg A; Mahar RK; Marks M; Marsh J; McGlothin A; Morpeth SC; Sud A; Ten Oever J; Yahav D; Bonten M; Bowen AC; Daneman N; Van Hal SJ; Heriot GS; Lewis RJ; Lye DC; McQuilten Z; Paterson DL; Owen Robinson J; Roberts JA; Scarborough M; Webb SA; Whiteway L; Tong SYC; Davis JS; Walls G; Goodman AL; Marsh J; Tong SYC; Savein K; Goodman AL; Mora J; McGlothlin A; Cheng MP; Anagnostou N; Acrhuleta S; Athan E; Barina L; Best E; Brett K; Burden H; Daley P; Davies J; Partha De P; Dishon-Benattar Y; Flanagan K; Grant J; Gregson D; Grimwade K; Hatcher J; Henderson A; Jankovic D; Johnstone J; Russel Lee I; Chew KL; Llewelyn M; Martson AG; McArthur C; McNeil D; Metcalf S; Nourse C; O'Sullivan M; Petrella L; Pett S; Rogers BA; Sim J; Soares MO; Stone N; Tilley R; Turner R; Tutone V; Underwood J; Voss L; Webb RH; Wilson H; Wuerz T, 2024, 'Early Oral Antibiotic Switch in Staphylococcus aureus Bacteraemia: The Staphylococcus aureus Network Adaptive Platform (SNAP) Trial Early Oral Switch Protocol', Clinical Infectious Diseases, 79, pp. 871 - 887, http://dx.doi.org/10.1093/cid/ciad666
McCabe L; Burns JE; Latifoltojar A; Post FA; Fox J; Pool E; Waters A; Santana B; Garvey L; Johnson M; McGuinness I; Chouhan M; Edwards J; Goodman AL; Cooke G; Murphy C; Collaco-Moraes Y; Webb H; Gregory A; Mohamed F; Rauchenberger M; Ryder SD; Sandford C; Baker JV; Angus B; Boesecke C; Orkin C; Punwani S; Clark A; Gilson R; Dunn D; Pett SL; Goodman A; Gregory A; Sy A; Dunn D; Turkova A; Vaughan H; Borg C, 2024, 'MAVMET trial: maraviroc and/or metformin for metabolic dysfunction associated fatty liver disease in adults with suppressed HIV', AIDS, 38, pp. 1513 - 1522, http://dx.doi.org/10.1097/QAD.0000000000003947
Aggarwal NR; Nordwall J; Braun DL; Chung L; Coslet J; Der T; Eriobu N; Ginde AA; Hayanga AJ; Highbarger H; Holodniy M; Horcajada JP; Jain MK; Kim K; Laverdure S; Lundgren J; Natarajan V; Nguyen HH; Pett SL; Phillips A; Poulakou G; Price DA; Robinson P; Rogers AJ; Sandkovsky U; Shaw-Saliba K; Sturek JM; Trautner BW; Waters M; Reilly C, 2024, 'Viral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19', Clinical Infectious Diseases, 78, pp. 1490 - 1503, http://dx.doi.org/10.1093/cid/ciad780
Abel K; Agnew E; Amos J; Armstrong N; Armstrong-James D; Ashfield T; Aston S; Baillie JK; Baldwin S; Barlow G; Bartle V; Bielicki J; Brown C; Carrol E; Clements M; Cooke G; Dane A; Dark P; Day J; de-Soyza A; Dowsey A; Evans S; Eyre D; Felton T; Fowler T; Foy R; Gannon K; Gerada A; Goodman A; Harman T; Hayward G; Holmes A; Hopkins S; Howard P; Howard A; Hsia Y; Knight G; Lemoine N; Koh J; Macgowan A; Marwick C; Moore C; O'Brien S; Oppong R; Peacock S; Pett S; Pouwels K; Queree C; Rahman N; Sculpher M; Shallcross L; Sharland M; Singh J; Stoddart K; Thomas-Jones E; Townsend A; Ustianowski A; Van Staa T; Walker S; White P; Wilson P; Buchan I; Woods B; Bower P; Llewelyn M; Hope W, 2024, 'System-wide approaches to antimicrobial therapy and antimicrobial resistance in the UK: the AMR-X framework', Lancet Microbe, 5, pp. e500 - e507, http://dx.doi.org/10.1016/S2666-5247(24)00003-X
Moore AEB; Burns JE; Sally D; Milinkovic A; Krokos G; John J; Rookyard C; Borca A; Pool ERM; Tostevin A; Harman A; Dulnoan DS; Gilson R; Arenas-Pinto A; Cook GJR; Saunders J; Dunn D; Blake GM; Pett SL, 2024, 'Bone turnover change after randomized switch from tenofovir disoproxil to tenofovir alafenamide fumarate in men with HIV', AIDS, 38, pp. 521 - 529, http://dx.doi.org/10.1097/QAD.0000000000003811
Hachicha-Maalej N; Collins IJ; Ades AE; Scott K; Judd A; Mostafa A; Chappell E; Hamdy-El-Sayed M; Gibb D; Pett S; Mariné-Barjoan E; Volokha A; Yazdanpanah Y; Deuffic-Burban S, 2024, 'Corrigendum to “Modelling the potential effectiveness of hepatitis C screening and treatment strategies during pregnancy in Egypt and Ukraine” [J Hepatol (2023) 937–946, (S0168827823000144), (10.1016/j.jhep.2022.12.032)]', Journal of Hepatology, 80, pp. 379, http://dx.doi.org/10.1016/j.jhep.2023.12.013
Scott K; Chappell E; Mostafa A; Volokha A; Najmi N; Ebeid F; Posokhova S; Sikandar R; Vasylyev M; Zulfiqar S; Kaminskyi V; Pett S; Malyuta R; Karpus R; Ayman Y; Ahmed RHM; Hamid S; El-Sayed MH; Gibb D; Judd A; Collins IJ, 2024, 'Acceptability of hepatitis C screening and treatment during pregnancy in pregnant women in Egypt, Pakistan, and Ukraine: A cross-sectional survey', Clinical Liver Disease, 23, http://dx.doi.org/10.1097/CLD.0000000000000140
Arenas-Pinto A; Bakewell N; Milinkovic A; Williams I; Vera J; Post FA; Anderson J; Beynon M; O'Brien A; Doyle N; Gilson R; Pett SL; Winston A; Sabin CA, 2024, 'Hepatic steatosis in people older and younger than fifty who are living with HIV and HIV-negative controls: A cross-sectional study nested within the POPPY cohort', HIV Medicine, 25, pp. 95 - 106, http://dx.doi.org/10.1111/hiv.13540
Hachicha-Maalej N; Lepers C; Collins IJ; Mostafa A; Ades AE; Judd A; Scott K; Gibb DM; Pett S; Indolfi G; Yazdanpanah Y; Sayed MHE; Deuffic-Burban S, 2024, 'Modelling the potential clinical and economic impact of universal antenatal hepatitis C (HCV) screening and providing treatment for pregnant women with HCV and their infants in Egypt: a cost-effectiveness study', BMJ Public Health, 2, pp. e000517, http://dx.doi.org/10.1136/bmjph-2023-000517
Hachicha-Maalej N; Collins IJ; Ades AE; Scott K; Judd A; Mostafa A; Chappell E; Hamdy-El-Sayed M; Gibb D; Pett S; Mariné-Barjoan E; Volokha A; Yazdanpanah Y; Deuffic-Burban S, 2023, 'Modelling the potential effectiveness of hepatitis C screening and treatment strategies during pregnancy in Egypt and Ukraine', Journal of Hepatology, 78, pp. 937 - 946, http://dx.doi.org/10.1016/j.jhep.2022.12.032
, 2023, 'Correction to: The Staphylococcus aureus Network Adaptive Platform Trial Protocol: New Tools for an Old Foe', Clinical Infectious Diseases, 76, pp. 1532 - 1533, http://dx.doi.org/10.1093/cid/ciac730
Flower B; Hung LM; Mccabe L; Ansari MA; Le Ngoc C; Vo Thi T; Vu Thi Kim H; Nguyen Thi Ngoc P; Phuong LT; Quang VM; Dang Trong T; Le Thi T; Nguyen Bao T; Kingsley C; Smith D; Hoglund RM; Tarning J; Kestelyn E; Pett SL; van Doorn R; Van Nuil JI; Turner H; Thwaites GE; Barnes E; Rahman M; Walker AS; Day JN; Chau NVV; Cooke GS, 2023, 'Efficacy of ultra-short, response-guided sofosbuvir and daclatasvir therapy for hepatitis C in a single-arm mechanistic pilot study', Elife, 12, http://dx.doi.org/10.7554/eLife.81801
Grundmann A; Wu CH; Hardwick M; Baillie JK; Openshaw PJM; Semple MG; Böhning D; Pett S; Michael BD; Thomas RH; Galea I, 2023, 'Fewer COVID-19 Neurological Complications with Dexamethasone and Remdesivir', Annals of Neurology, 93, pp. 88 - 102, http://dx.doi.org/10.1002/ana.26536
Sy A; McCabe L; Hudson E; Ansari AM; Pedergnana V; Lin SK; Santana S; Fiorino M; Ala A; Stone B; Smith M; Nelson M; Barclay ST; McPherson S; Ryder SD; Collier J; Barnes E; Walker AS; Pett SL; Cooke G; Jones C; Gilson R; Verma S; Bhagani S; Ch'Ng C; Wiselka M; Forton D; Halford R; Nguyen D; Smith D; Dennis E; Hudson F, 2023, 'Utility of a buccal swab point-of-care test for the IFNL4 genotype in the era of direct acting antivirals for hepatitis C virus', Plos One, 18, http://dx.doi.org/10.1371/journal.pone.0280551
Back to profile page